PIAS3 and squamous cell neoplasm: Thus, we hypothesize that SCC inhibition may be achieved clinically by reversing the PIAS3 deficiency present in a subgroup of squamous cell tumors, restoring its inhibition of STAT3-mediated cell proliferation.